PSCHvsXBIETF Comparison
VS
Invesco S&P SmallCap Health Care ETF (PSCH) and State Street SPDR S&P Biotech ETF (XBI) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. PSCH is less expensive with a Total Expense Ratio (TER) of 0.29%, versus 0.35% for XBI. PSCH is up 8.5% year-to-date (YTD) with -$17M in YTD flows. XBI performs better with 9.68% YTD performance, and -$269M in YTD flows. Run a side-by-side ETF comparison of PSCH and XBI below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
PSCH vs XBI performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 06/12/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PSCH XBI | +6.00%-0.89% | +19.98%+9.09% | +8.50%+9.68% | +16.31%+59.15% | +8.09%+51.71% | -24.67%-1.65% |
| Flows | PSCH XBI | +$492K-$91M | -$3M-$210M | -$17M-$269M | -$27M+$444M | -$150M-$1.14B | -$235M+$810M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PSCH XBI | +21.44%+32.47% | +20.54%+26.10% | +21.72%+27.60% | +22.89%+32.77% |
| Max drawdown | PSCH XBI | -4.51%-8.56% | -15.36%-9.66% | -22.80%-32.94% | -47.23%-54.69% |
| Max drawdown duration | PSCH XBI | 13d54d | 168d76d | 478d331d | 1811d1754d |
Trading data
PSCH | XBI | |
Last sale 6/12/2026 at 1:30 PM | $47.79 | $133.79 |
| Previous close 06/11/2026 | $47.74 | $132.74 |
| Consolidated volume 06/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of May 29, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
PSCH | XBI | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 6/12/2026 at 1:30 PM
Live
Closed
PSCH | XBI | |
|---|---|---|
| Last price | $47.79 | $133.79 |
| 1D performance | +0.10% | +0.79% |
| AuM | $140.15 M | $8.30 B |
| E/R | 0.29% | 0.35% |
Characteristics
PSCH | XBI | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | Invesco | State Street Investment Management |
| Benchmark | S&P SmallCap 600 Capped Health Care Index | S&P Biotechnology Select Industry Index |
| N° of holdings | 71 | 119 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | April 7, 2010 | January 31, 2006 |
| ESG | No | No |
Advertisement
Exposure
Countries
PSCH
USA
96.15%
Other
3.85%
XBI
USA
94.81%
Other
5.19%
Sectors
PSCH
Health Care
90.67%
Other
9.33%
XBI
Health Care
85.15%
Other
14.85%
Advertisement
Diversification
PSCH
Total weight of top 15 holdings out of 15
44.63%
XBI
Total weight of top 15 holdings out of 15
20.97%
Top 15 holdings
Data as of April 30, 2026
PSCH
MOLINA HLTHCRE
4.96%
KRYSTAL BIOTECH INC
3.79%
GLAUKOS
3.77%
US10950A1060
3.46%
TELEFLEX
3.21%
PROTAGONIST THERAPEUTICS INC
3.11%
ALKERMES
3.00%
PTC THERAPEUTI/D
2.99%
TG THERAPEUTICS
2.59%
LIGAND PHARMACEUTICALS
2.56%
CORCEPT THERAPEUTICS
2.33%
US45579U1097
2.30%
APELLIS PHARMACEUTICALS
2.26%
RADNET
2.16%
MERIT MEDICAL SYSTEMS
2.15%
XBI
APELLIS PHARMACEUTICALS
1.87%
REVOLUTION MEDICINES INC
1.65%
TRAVERE THERAPEUTICS INC
1.62%
ARROWHEAD PHARMACEUTICALS INC
1.44%
TWIST BIOSCIENCE CORP
1.42%
US86627T1088
1.40%
ALKERMES
1.38%
TG THERAPEUTICS
1.37%
MADRIGAL PHARMACEUTICALS INC
1.36%
BEAM THERAPEUTICS
1.32%
US03770N1019
1.26%
SCHOLAR ROCK HOLDING CORP
1.23%
US74006W2070
1.22%
EXELIXIS
1.21%
MIRUM PHARMACEUTICALS INC
1.21%
Frequently asked questions about PSCH and XBI
How have the PSCH and XBI ETFs performed in 2026?
As of June 12, 2026, PSCH is up 8.5% year-to-date (YTD), while XBI has returned 9.68%. That puts XBI better performer ahead so far this year.
Which ETF is attracting more investor money: PSCH or XBI?
Year-to-date, the PSCH ETF saw -$17M in flows, compared to -$269M for XBI.
Which ETF is more volatile: PSCH or XBI?
Over the past year, PSCH had a volatility of 20.54%, while XBI experienced 26.1%.
Which ETF is bigger: PSCH or XBI?
As of June 12, 2026, PSCH holds $140.15 M in assets under management (AUM), while XBI manages $8.30 B.
What sectors do the PSCH and XBI ETFs invest in?
PSCH leans toward sectors like Health Care. Meanwhile, XBI focuses on Health Care.
What are the top holdings of the PSCH ETF and XBI ETF?
PSCH top holdings include MOLINA HLTHCRE, KRYSTAL BIOTECH INC and GLAUKOS. XBI holds in its top three: APELLIS PHARMACEUTICALS, REVOLUTION MEDICINES INC and TRAVERE THERAPEUTICS INC.
Which ETF is more diversified: PSCH or XBI?
PSCH holds 75 securities with 44.63% of its assets in the top 15. XBI has 148 securities and a top 15 weight of 20.97%.
Advertisement
Latest news about PSCH & XBI
Small-Cap Biotech ETFs: High-Risk, High-Reward Opportunities
September 18, 2025
XBI
Are Biotechnology ETFs In the Midst of a Comeback?
August 20, 2025
XBI
Two biotech ETFs to watch for the rest of 2022 and beyond
September 13, 2022
XBI
Biotech ETFs – Investing in Health Innovation
July 21, 2022
XBI
Advertisement
Advertisement
